Belgium · 
Who invested in etherna immunotherapies?
etherna immunotherapies's investors include European Commission, Omega Funds, EQT Life Sciences and Boehringer Ingelheim Venture Fund.
Belgium · Series B startup
Who invested in etherna immunotherapies
Funding summaryUpdated 26 Oct 2026
$39Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $39MAug 2022
- Investors
- 4
The rounds
- Aug 2022Series B$39M
Source recorded
Founders and team
From etherna immunotherapies's own website: 5 on the team.
- Bernard SagaertChief Executive Officer
- Philip Van der AuweraVP HR & Operations
- Stefaan De KokerVP Technology & Innovation
- Florence LambolezDirector Pharmacology
- Lien VangansewinkelFinance Director
Everyone who backed them
European CommissionVC firm1round
Boehringer Ingelheim Venture FundCorporate VC1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about etherna immunotherapies
How much has etherna immunotherapies raised?
etherna immunotherapies has raised $39M across 1 round since 2022.
When did etherna immunotherapies last raise?
etherna immunotherapies's most recent round was a Series B of $39M in Aug 2022.
What was etherna immunotherapies's biggest round?
Its most recent round, $39M in Aug 2022, is also its largest on record.
Who backed etherna immunotherapies first?
etherna immunotherapies's first round on record, in Aug 2022, was backed by European Commission, Omega Funds and EQT Life Sciences and 1 others.
What stage is etherna immunotherapies at?
etherna immunotherapies's latest named round is a Series B, in Aug 2022.
Where is etherna immunotherapies based?
etherna immunotherapies is based in Belgium.
Companies like etherna immunotherapies
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.